Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an...

Related Keywords

Keitha Goldan ,Sharon Klahre ,Linkedin ,Twitter ,Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals ,Nasdaq ,Chief Financial Officer ,Nasdaq Global Select Market ,